Treating Young Children With Attention Deficit Hyperactivity Disorder
Status:
NOT_YET_RECRUITING
Trial end date:
2030-07-01
Target enrollment:
Participant gender:
Summary
This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Phase:
PHASE4
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
Boston Children's Hospital, Boston, MA, USA Children's Hospital of Philadelphia Children's Mercy Hospital Kansas City Developmental Behavioral Pediatrics Research Network Patient-Centered Outcomes Research Institute Stanford University